Roche Showcases Advancements in Alzheimer’s Diagnostics at CTAD 2024
(IN BRIEF) At the CTAD 2024 congress in Madrid, Roche presented new data on its Elecsys® Amyloid Plasma Panel and Elecsys ptau181, demonstrating their effectiveness in diagnosing Alzheimer’s disease. The blood-based test showed a negative predictive value of 96.2% in ruling out Alzheimer’s-related amyloid pathology, potentially eliminating the need for invasive testing. Conducted across the US and Europe with 492 participants, the trial indicated strong performance across diverse demographics. Matt Sause, CEO of Roche Diagnostics, highlighted the test’s ability to provide reassurance to patients and facilitate timely diagnoses. With a significant portion of individuals with Alzheimer’s remaining undiagnosed, Roche aims to expedite the diagnostic process and is well-positioned to rapidly scale testing capabilities upon regulatory approval, reinforcing its commitment to advancing Alzheimer’s diagnostics and therapies.
(PRESS RELEASE) BASEL, 31-Oct-2024 — /EuropaWire/ — On October 31, 2024, Roche (SIX: RO, ROG; OTCQX: RHHBY) presented new data on its Elecsys® Amyloid Plasma Panel and Elecsys ptau181 at the 17th Clinical Trials in Alzheimer’s Disease congress (CTAD) in Madrid, highlighting significant progress in diagnostics for Alzheimer’s disease. The data demonstrated the test’s potential to accurately rule out Alzheimer’s-related amyloid pathology, potentially eliminating the need for further invasive procedures.
This innovative blood-based test has emerged from the largest clinical trial of its kind, showing a remarkable negative predictive value (NPV) of 96.2% in ruling out Alzheimer’s disease in patients undergoing evaluation for cognitive impairment. Conducted across multiple centers in the US and Europe with 492 participants, the trial indicated that the test performed consistently well across diverse demographics, including various age groups and health conditions.
Matt Sause, CEO of Roche Diagnostics, commented on the study’s findings, stating, “The results suggest that a straightforward blood test could reliably rule out amyloid pathology, providing crucial reassurance for patients and their families. Alzheimer’s disease is a pressing global health challenge, and this test could help facilitate timely and accurate diagnoses, enabling patients to receive appropriate care sooner.”
The Elecsys Amyloid Plasma Panel, which received FDA Breakthrough Device Designation in July 2023, measures phosphorylated Tau (pTau) 181 protein and apolipoprotein E4 in plasma. It represents a pioneering effort in the industry to assess clinical performance in a patient population reflective of those who would benefit from such testing. The study included a diverse array of patients to ensure broad applicability across different regions and ethnicities.
Roche also presented data for its Elecsys pTau 217 assay, which is currently under development and has similarly received FDA Breakthrough Device Designation this year. The findings reveal high accuracy in detecting amyloid pathology when compared to other existing tests.
With up to 75% of individuals experiencing Alzheimer’s symptoms remaining undiagnosed, Roche is addressing critical barriers to early diagnosis. On average, patients wait 2.8 years after the onset of symptoms for a formal diagnosis. The company emphasizes the importance of expediting the diagnostic journey to ensure timely access to emerging therapies.
Roche’s extensive network of established solutions positions it well to rapidly scale testing capabilities once regulatory approvals are obtained, ensuring that patients can access these advancements promptly. Committed to improving detection and treatment of Alzheimer’s disease, Roche is developing comprehensive solutions to diagnose and monitor the condition effectively while advancing research into investigational therapies.
For further insights into Roche’s progress in Alzheimer’s diagnostics and treatment, additional information is available through their official channels.
About the Elecsys Amyloid Plasma Panel
This product is currently under development and not commercially available. The below information reflects Roche’s plans for these products if they are approved by regulatory bodies for clinical use in the future:
The Elecsys Amyloid Plasma Panel measures phosphorylated Tau (pTau) 181 protein assay and apolipoprotein (APOE) E4 assay in human blood plasma. Elevations in pTau181 occur in the early stages of Alzheimer’s disease, while the presence of APOE4 constitutes the most common genetic risk factor for Alzheimer’s disease. The result is intended for consideration in conjunction with other clinical information to advise for further confirmatory testing with amyloid positron emission tomography (PET) or cerebrospinal fluid (CSF) testing. Patients testing negative with the Elecsys Amyloid Plasma Panel are unlikely to be amyloid positive and should be investigated for other causes of cognitive decline.
About Elecsys pTau217
This product is currently under development and not commercially available. The below information reflects Roche’s plans for these products if they are approved by regulatory bodies for clinical use in the future:
Elecsys Phospho-Tau (217P) is intended to be an in-vitro diagnostic immunoassay for the quantitative determination of the protein Phospho-Tau (217P) (pTau217) in human plasma from individuals aged 60 years and older. The test is intended for use as an aid in identifying amyloid pathology, a pathological feature of Alzheimer’s disease.
A positive Elecsys pTau217 result indicates a high likelihood of having a positive amyloid PET/CSF result.
A negative Elecsys pTau217 result indicates a high likelihood of having a negative amyloid PET/ CSF result.
An indeterminate pTau217 result indicates uncertainty on the amyloid PET/CSF result. The pTau217 result should be used in the diagnostic pathway in conjunction with other clinical information.
About Roche in Alzheimer’s disease
With more than two decades of scientific research in Alzheimer’s disease, Roche is working towards a day when we can detect and treat the disease early, in order to stop or even prevent its progression to preserve what makes people who they are. Today, the company’s Alzheimer’s disease portfolio spans investigational medicines for different targets, types and stages of the disease, including trontinemab. On the diagnostics side, it also includes approved and investigational tools, including digital and blood-based tests and CSF assays, aiming to more effectively detect, diagnose and monitor the disease. Yet the global challenges of Alzheimer’s disease go well beyond the capabilities of science, and making a meaningful impact requires collaboration both within the Alzheimer’s community and outside of healthcare. Roche will continue to work together with numerous partners with the hope to transform millions of lives.
About Roche
Founded in 1896 in Basel, Switzerland, as one of the first industrial manufacturers of branded medicines, Roche has grown into the world’s largest biotechnology company and the global leader in in-vitro diagnostics. The company pursues scientific excellence to discover and develop medicines and diagnostics for improving and saving the lives of people around the world. We are a pioneer in personalised healthcare and want to further transform how healthcare is delivered to have an even greater impact. To provide the best care for each person we partner with many stakeholders and combine our strengths in Diagnostics and Pharma with data insights from the clinical practice.
For over 125 years, sustainability has been an integral part of Roche’s business. As a science-driven company, our greatest contribution to society is developing innovative medicines and diagnostics that help people live healthier lives. Roche is committed to the Science Based Targets initiative and the Sustainable Markets Initiative to achieve net zero by 2045.
Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan. For more information, please visit www.roche.com.
All trademarks used or mentioned in this release are protected by law.
References
[1] Kirste I, et al, Revamping Alzheimer’s Disease Diagnostics: Evaluating Future IVD Plasma p-Tau 181 and ApoE4 Immunoassays for Amyloid Detection in a Multi-Center Study Reflective of Routine Clinical Practice, presented at CTAD, October 2024.
[2] Life Expectancy Following Diagnosis Of Alzheimer’s Disease Depends On Age At Diagnosis, Johns Hopkins Bloomberg School of Public Health, November 18, 2002, https://publichealth.jhu.edu/2002/alzheimer-age
Media Contacts:
Media Relations:
Phone: +41 61 688 8888
e-mail: media.relations@roche.com
SOURCE: Roche
EDITOR’S PICK:
Digi Communications N.V. announces the conclusion of a Memorandum of Understanding by its subsidiary in Romania
Digi Communications N.V. announces that the Company’s Portuguese subsidiary finalised the transaction with LORCA JVCO Limited
Digi Communications N.V. announces that the Portuguese Competition Authority has granted clearance for the share purchase agreement concluded by the Company’s subsidiary in Portugal
OMRON Healthcare introduceert nieuwe bloeddrukmeters met AI-aangedreven AFib-detectietechnologie; lancering in Europa september 2024
OMRON Healthcare dévoile de nouveaux tensiomètres dotés d’une technologie de détection de la fibrillation auriculaire alimentée par l’IA, lancés en Europe en septembre 2024
OMRON Healthcare presenta i nuovi misuratori della pressione sanguigna con tecnologia di rilevamento della fibrillazione atriale (AFib) basata sull’IA, in arrivo in Europa a settembre 2024
OMRON Healthcare presenta los nuevos tensiómetros con tecnología de detección de fibrilación auricular (FA) e inteligencia artificial (IA), que se lanzarán en Europa en septiembre de 2024
Alegerile din Moldova din 2024: O Bătălie pentru Democrație Împotriva Dezinformării
Northcrest Developments launches design competition to reimagine 2-km former airport Runway into a vibrant pedestrianized corridor, shaping a new era of placemaking on an international scale
The Road to Sustainable Electric Motors for EVs: IDTechEx Analyzes Key Factors
Infrared Technology Breakthroughs Paving the Way for a US$500 Million Market, Says IDTechEx Report
MegaFair Revolutionizes the iGaming Industry with Skill-Based Games
European Commission Evaluates Poland’s Media Adherence to the Right to be Forgotten
Global Race for Autonomous Trucks: Europe a Critical Region Transport Transformation
Digi Communications N.V. confirms the full redemption of €450,000,000 Senior Secured Notes
AT&T Obtiene Sentencia Contra Grupo Salinas Telecom, Propiedad de Ricardo Salinas, Sus Abogados se Retiran Mientras Él Mueve Activos Fuera de EE.UU. para Evitar Pagar la Sentencia
Global Outlook for the Challenging Autonomous Bus and Roboshuttle Markets
Evolving Brain-Computer Interface Market More Than Just Elon Musk’s Neuralink, Reports IDTechEx
Latin Trails Wraps Up a Successful 3rd Quarter with Prestigious LATA Sustainability Award and Expands Conservation Initiatives ↗️
Astor Asset Management 3 Ltd leitet Untersuchung für potenzielle Sammelklage gegen Ricardo Benjamín Salinas Pliego von Grupo ELEKTRA wegen Marktmanipulation und Wertpapierbetrug ein
Digi Communications N.V. announces that the Company’s Romanian subsidiary exercised its right to redeem the Senior Secured Notes due in 2025 in principal amount of €450,000,000
Astor Asset Management 3 Ltd Inicia Investigación de Demanda Colectiva Contra Ricardo Benjamín Salinas Pliego de Grupo ELEKTRA por Manipulación de Acciones y Fraude en Valores
Astor Asset Management 3 Ltd Initiating Class Action Lawsuit Inquiry Against Ricardo Benjamín Salinas Pliego of Grupo ELEKTRA for Stock Manipulation & Securities Fraud
Digi Communications N.V. announced that its Spanish subsidiary, Digi Spain Telecom S.L.U., has completed the first stage of selling a Fibre-to-the-Home (FTTH) network in 12 Spanish provinces
Natural Cotton Color lancia la collezione “Calunga” a Milano
Astor Asset Management 3 Ltd: Salinas Pliego Incumple Préstamo de $110 Millones USD y Viola Regulaciones Mexicanas
Astor Asset Management 3 Ltd: Salinas Pliego Verstößt gegen Darlehensvertrag über 110 Mio. USD und Mexikanische Wertpapiergesetze
ChargeEuropa zamyka rundę finansowania, której przewodził fundusz Shift4Good tym samym dokonując historycznej francuskiej inwestycji w polski sektor elektromobilności
Strengthening EU Protections: Robert Szustkowski calls for safeguarding EU citizens’ rights to dignity
Digi Communications NV announces the release of H1 2024 Financial Results
Digi Communications N.V. announces that conditional stock options were granted to a director of the Company’s Romanian Subsidiary
Digi Communications N.V. announces Investors Call for the presentation of the H1 2024 Financial Results
Digi Communications N.V. announces the conclusion of a share purchase agreement by its subsidiary in Portugal
Digi Communications N.V. Announces Rating Assigned by Fitch Ratings to Digi Communications N.V.
Digi Communications N.V. announces significant agreements concluded by the Company’s subsidiaries in Spain
SGW Global Appoints Telcomdis as the Official European Distributor for Motorola Nursery and Motorola Sound Products
Digi Communications N.V. announces the availability of the instruction regarding the payment of share dividend for the 2023 financial year
Digi Communications N.V. announces the exercise of conditional share options by the executive directors of the Company, for the year 2023, as approved by the Company’s Ordinary General Shareholders’ Meetings from 18th May 2021 and 28th December 2022
Digi Communications N.V. announces the granting of conditional stock options to Executive Directors of the Company based on the general shareholders’ meeting approval from 25 June 2024
Digi Communications N.V. announces the OGMS resolutions and the availability of the approved 2023 Annual Report
Czech Composer Tatiana Mikova Presents Her String Quartet ‘In Modo Lidico’ at Carnegie Hall
SWIFTT: A Copernicus-based forest management tool to map, mitigate, and prevent the main threats to EU forests
WickedBet Unveils Exciting Euro 2024 Promotion with Boosted Odds
Museum of Unrest: a new space for activism, art and design
Digi Communications N.V. announces the conclusion of a Senior Facility Agreement by companies within Digi Group
Digi Communications N.V. announces the agreements concluded by Digi Romania (formerly named RCS & RDS S.A.), the Romanian subsidiary of the Company
Green Light for Henri Hotel, Restaurants and Shops in the “Alter Fischereihafen” (Old Fishing Port) in Cuxhaven, opening Summer 2026
Digi Communications N.V. reports consolidated revenues and other income of EUR 447 million, adjusted EBITDA (excluding IFRS 16) of EUR 140 million for Q1 2024
Digi Communications announces the conclusion of Facilities Agreements by companies from Digi Group
Digi Communications N.V. Announces the convocation of the Company’s general shareholders meeting for 25 June 2024 for the approval of, among others, the 2023 Annual Report
Digi Communications NV announces Investors Call for the presentation of the Q1 2024 Financial Results
Digi Communications intends to propose to shareholders the distribution of dividends for the fiscal year 2023 at the upcoming General Meeting of Shareholders, which shall take place in June 2024
Digi Communications N.V. announces the availability of the Romanian version of the 2023 Annual Report
Digi Communications N.V. announces the availability of the 2023 Annual Report
International Airlines Group adopts Airline Economics by Skailark ↗️
BevZero Spain Enhances Sustainability Efforts with Installation of Solar Panels at Production Facility
Digi Communications N.V. announces share transaction made by an Executive Director of the Company with class B shares
BevZero South Africa Achieves FSSC 22000 Food Safety Certification
Digi Communications N.V.: Digi Spain Enters Agreement to Sell FTTH Network to International Investors for Up to EUR 750 Million
Patients as Partners® Europe Announces the Launch of 8th Annual Meeting with 2024 Keynotes and Topics
driveMybox continues its international expansion: Hungary as a new strategic location
Monesave introduces Socialised budgeting: Meet the app quietly revolutionising how users budget
Digi Communications NV announces the release of the 2023 Preliminary Financial Results
Digi Communications NV announces Investors Call for the presentation of the 2023 Preliminary Financial Results
Lensa, един от най-ценените търговци на оптика в Румъния, пристига в България. Първият шоурум е открит в София
Criando o futuro: desenvolvimento da AENO no mercado de consumo em Portugal
Digi Communications N.V. Announces the release of the Financial Calendar for 2024
Customer Data Platform Industry Attracts New Participants: CDP Institute Report
eCarsTrade annonce Dirk Van Roost au poste de Directeur Administratif et Financier: une décision stratégique pour la croissance à venir
BevZero Announces Strategic Partnership with TOMSA Desil to Distribute equipment for sustainability in the wine industry, as well as the development of Next-Gen Dealcoholization technology
Digi Communications N.V. announces share transaction made by a Non-Executive Director of the Company with class B shares
Digi Spain Telecom, the subsidiary of Digi Communications NV in Spain, has concluded a spectrum transfer agreement for the purchase of spectrum licenses
Эксперт по торговле акциями Сергей Левин запускает онлайн-мастер-класс по торговле сырьевыми товарами и хеджированию
Digi Communications N.V. announces the conclusion by Company’s Portuguese subsidiary of a framework agreement for spectrum usage rights
North Texas Couple Completes Dream Purchase of Ouray’s Iconic Beaumont Hotel
Предприниматель и филантроп Михаил Пелег подчеркнул важность саммита ООН по Целям устойчивого развития 2023 года в Нью-Йорке
Digi Communications NV announces the release of the Q3 2023 Financial Results
IQ Biozoom Innovates Non-Invasive Self-Testing, Empowering People to Self-Monitor with Laboratory Precision at Home
BevZero Introduces Energy Saving Tank Insulation System to Europe under name “BevClad”
Motorvision Group reduces localization costs using AI dubbing thanks to partnering with Dubformer
Digi Communications NV Announces Investors Call for the Q3 2023 Financial Results
Jifiti Granted Electronic Money Institution (EMI) License in Europe
Предприниматель Михаил Пелег выступил в защиту образования и грамотности на мероприятии ЮНЕСКО, посвящённом Международному дню грамотности
VRG Components Welcomes New Austrian Independent Agent
Digi Communications N.V. announces that Digi Spain Telecom S.L.U., its subsidiary in Spain, and abrdn plc have completed the first investment within the transaction having as subject matter the financing of the roll out of a Fibre-to-the-Home (“FTTH”) network in Andalusia, Spain
Продюсер Михаил Пелег, как сообщается, работает над новым сериалом с участием крупной голливудской актрисы
Double digit growth in global hospitality industry for Q4 2023
ITC Deploys Traffic Management Solution in Peachtree Corners, Launches into United States Market
Cyviz onthult nieuwe TEMPEST dynamische controlekamer in Benelux, Nederland
EU-Funded CommuniCity Launches its Second Open Call
Astrologia pode dar pistas sobre a separação de Sophie Turner e Joe Jonas
La astrología puede señalar las razones de la separación de Sophie Turner y Joe Jonas
Empowering Europe against infectious diseases: innovative framework to tackle climate-driven health risks
Montachem International Enters Compostable Materials Market with Seaweed Resins Company Loliware
Digi Communications N.V. announces that its Belgian affiliated companies are moving ahead with their operations
Digi Communications N.V. announces the exercise of conditional share options by an executive director of the Company, for the year 2022, as approved by the Company’s Ordinary General Shareholders’ Meeting from 18 May 2021
Digi Communications N.V. announces the availability of the instruction regarding the payment of share dividend for the 2022 financial year
Digi Communications N.V. announces the availability of the 2022 Annual Report
Digi Communications N.V. announces the general shareholders’ meeting resolutions from 18 August 2023 approving amongst others, the 2022 Annual Accounts
Русские эмигранты усиливают призывы «Я хочу, чтобы вы жили» через искусство
BevZero Introduces State-of-the-Art Mobile Flash Pasteurization Unit to Enhance Non-Alcoholic Beverage Stability at South Africa Facility
Russian Emigrés Amplify Pleas of “I Want You to Live” through Art
Digi Communications NV announces the release of H1 2023 Financial Results
Digi Communications NV Announces Investors Call for the H1 2023 Financial Results
Digi Communications N.V. announces the convocation of the Company’s general shareholders meeting for 18 August 2023 for the approval of, among others, the 2022 Annual Report
“Art Is Our Weapon”: Artists in Exile Deploy Their Talents in Support of Peace, Justice for Ukraine
Digi Communications N.V. announces the availability of the 2022 Annual Financial Report
“AmsEindShuttle” nuevo servicio de transporte que conecta el aeropuerto de Eindhoven y Ámsterdam
Un nuovo servizio navetta “AmsEindShuttle” collega l’aeroporto di Eindhoven ad Amsterdam
Digi Communications N.V. announces the conclusion of an amendment agreement to the Facility Agreement dated 26 July 2021, by the Company’s Spanish subsidiary
Digi Communications N.V. announces an amendment of the Company’s 2023 financial calendar
iGulu F1: Brewing Evolution Unleashed
Почему интерактивная «Карта мира» собрала ключевые антивоенные сообщества россиян по всему миру и становится для них важнейшим инструментом
Hajj Minister meets EU ambassadors to Saudi Arabia
Online Organizing Platform “Map of Peace” Emerges as Key Tool for Diaspora Activists
Digi Communications N.V. announces that conditional stock options were granted to executive directors of the Company based on the general shareholders’ meeting approval from 18 May 2021
Digi Communications N.V. announces the release of the Q1 2023 financial results
AMBROSIA – A MULTIPLEXED PLASMO-PHOTONIC BIOSENSING PLATFORM FOR RAPID AND INTELLIGENT SEPSIS DIAGNOSIS AT THE POINT-OF-CARE
Digi Communications NV announces Investors Call for the Q1 2023 Financial Results presentation
Digi Communications N.V. announces the amendment of the Company’s 2023 financial calendar
Digi Communications N.V. announces the conclusion of two Facilities Agreements by the Company’s Romanian subsidiary
Digi Communications N.V. announces the conclusion of a Senior Facility Agreement by the Company’s Romanian subsidiary
Patients as Partners Europe Returns to London and Announces Agenda Highlights
GRETE PROJECT RESULTS PRESENTED TO TEXTILE INDUSTRY STAKEHOLDERS AT INTERNATIONAL CELLULOSE FIBRES CONFERENCE
Digi Communications N.V. announces Digi Spain Telecom S.L.U., its subsidiary in Spain, entered into an investment agreement with abrdn to finance the roll out of a Fibre-to-the-Home (FTTH) network in Andalusia, Spain
XSpline SPA / University of Linz (Austria): the first patient has been enrolled in the international multicenter clinical study for the Cardiac Resynchronization Therapy DeliveRy guided by non-Invasive electrical and VEnous anatomy assessment (CRT-DRIVE)
Franklin Junction Expands Host Kitchen® Network To Europe with Digital Food Hall Pioneer Casper
Unihertz a dévoilé un nouveau smartphone distinctif, Luna, au MWC 2023 de Barcelone
Unihertz Brachte ein Neues, Markantes Smartphone, Luna, auf dem MWC 2023 in Barcelona
Editor’s pick archive….
Source link : http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=672428cd41b74e479e502c669166e84a&url=https%3A%2F%2Fnews.europawire.eu%2Froche-showcases-advancements-in-alzheimers-diagnostics-at-ctad-2024%2Feu-press-release%2F2024%2F10%2F31%2F13%2F47%2F59%2F143122%2F&c=3230279934057388719&mkt=de-de
Author :
Publish date : 2024-10-31 06:21:00
Copyright for syndicated content belongs to the linked Source.